Skinceuticals - Silymarin CF Vitamin C Salicylic Acid Antioxidant Serum30mlSilymarin CF is a powerful vitamin C triple antioxidant serum formulated specifically for oily and blemish-prone skin. SkinCeuticals research shows that specific combinations of ant
30ml
Silymarin CF is a powerful vitamin C triple antioxidant serum formulated specifically for oily and blemish-prone skin. SkinCeuticals research shows that specific combinations of antioxidants, when effectively formulated, perform synergistically to provide results superior to each single antioxidant formulation. The result of six years of research and development, this lightweight formula helps reduce oil oxidation, control excess sebum and improve the appearance of blemishes and signs of ageing. Silymarin CF contains 0.5% Silymarin, optimized concentration of milk thistle plant.
15% L-ascorbic acid (pure vitamin C antioxidant), 0.5% Ferulic acid, plant-based antioxidant and 0.5% Salicylic acid (Beta hydroxy acid). It provides environmental protection for oily, blemish-prone skin and fights against visible skin ageing.
*Clinical study 35 subjects (China, 2020)
**8 clinical study, 55 women (USA, 2019)
***12 week clinical study, 60 women (Brazil, 2020)
When skins oils oxidize, free radicals are generated that can damage skin and create favourable conditions for blemishes. This powerful antioxidant helps reinforce the skins natural protection from free radical damage.
How to use:
In the morning, after cleansing, apply 4-5 drops of Silymarin CF to face, neck and chest.
Ingredients:
Aqua / Water Alcohol Denat. Ascorbic Acid Propylene Glycol Dipropylene Glycol Laureth-23 Silybum Marianum Fruit Extract Sodium Citrate Salicylic Acid Ferulic Acid
*Please be aware that ingredient lists for products in our brand are updated regularly. Please refer to the ingredient list on the product package for the most up-to-date list of ingredients to ensure it is suitable for your personal use.
***The sale of this product is limited to6 units per order***
Reviews
There are no reviews yet.